Alcaptonurie (Romanian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Alcaptonurie" in Romanian language version.

refsWebsite

Global rank Romanian rank

15nih.gov

4^th place

14doi.org

2^nd place

3^rd place

1worldcat.org

5^th place

11^th place

1zenodo.org

621^st place

1,171^st place

1harvard.edu

18^th place

27^th place

doi.org

„Recent advances in management of alkaptonuria (invited review; best practice article)”. J. Clin. Pathol. 66 (5): 367–73. mai 2013. doi:10.1136/jclinpath-2012-200877. PMID 23486607.
„The biology of hyperpigmentation syndromes”. Pigment Cell Melanoma Res. 27 (4): 512–24. iulie 2014. doi:10.1111/pcmr.12235. PMID 24612852.
Lindner, Moritz; Bertelmann, Thomas (30 ianuarie 2014). „On the ocular findings in ochronosis: a systematic review of literature”. BMC Ophthalmology (în engleză). 14 (1): 12. doi:10.1186/1471-2415-14-12. ISSN 1471-2415. PMC 3915032 . PMID 24479547.
Zatkova A (decembrie 2011). „An update on molecular genetics of Alkaptonuria (AKU)”. J. Inherit. Metab. Dis. 34 (6): 1127–36. doi:10.1007/s10545-011-9363-z. PMID 21720873.
White, A.; c. Tchan, M. (2017). „Nitisinone-Induced Keratopathy in Alkaptonuria: A Challenging Diagnosis Despite Clinical Suspicion”. Jimd Reports. 40: 7–9. doi:10.1007/8904_2017_56. ISBN 978-3-662-57879-7. PMC 6122027 . PMID 28879639.
Stewart, R. M.; Briggs, M. C.; Jarvis, J. C.; Gallagher, J. A.; Ranganath, L. (2014). „Reversible Keratopathy Due to Hypertyrosinaemia Following Intermittent Low-Dose Nitisinone in Alkaptonuria: A Case Report”. Jimd Reports. 17: 1–6. doi:10.1007/8904_2014_307. ISBN 978-3-662-44577-8. PMC 4241204 . PMID 24997710.
Davison, A. S.; Strittmatter, N.; Sutherland, H.; Hughes, A. T.; Hughes, J.; Bou-Gharios, G.; Milan, A. M.; Goodwin, R. J.; Ranganath, L. R. (2019). „Assessing the effect of nitisinone induced hypertyrosinaemia on monoamine neurotransmitters in brain tissue from a murine model of alkaptonuria using mass spectrometry imaging”. Metabolomics. 15 (5): 68. doi:10.1007/s11306-019-1531-4. PMC 6488549 . PMID 31037385.
Norman, B. P.; Davison, A. S.; Hughes, J. H.; Sutherland, H.; Wilson, P. J.; Berry, N. G.; Hughes, A. T.; Milan, A. M.; Jarvis, J. C. (2021). „Metabolomic studies in the inborn error of metabolism alkaptonuria reveal new biotransformations in tyrosine metabolism”. Genes & Diseases. 9 (4): 1129–1142. doi:10.1016/j.gendis.2021.02.007. PMC 9170613 . PMID 35685462 Verificați valoarea |pmid= (ajutor).
Garrod AE (1902). „The incidence of alkaptonuria: a study in clinical individuality”. Lancet. 2 (4137): 1616–20. doi:10.1016/S0140-6736(01)41972-6. PMC 2230159 . PMID 8784780. Reproduced in Garrod AE (2002). „The incidence of alkaptonuria: a study in chemical individuality. 1902 classical article”. Yale Journal of Biology and Medicine. 75 (4): 221–31. PMC 2588790 . PMID 12784973.
Garrod AE (1908). „The Croonian lectures on inborn errors of metabolism: lecture II: alkaptonuria”. Lancet. 2 (4428): 73–79. doi:10.1016/s0140-6736(01)78041-5.
„The nature of the defect in tyrosine metabolism in alcaptonuria”. Journal of Biological Chemistry. 230 (1): 251–60. 1 ianuarie 1958. doi:10.1016/S0021-9258(18)70560-7. PMID 13502394.
„The molecular basis of alkaptonuria”. Nature Genetics. 14 (1): 19–24. 1996. doi:10.1038/ng0996-19. PMID 8782815.
„Biochemical identification of homogentisic acid pigment in an ochronotic egyptian mummy”. Science. 197 (4303): 566–68. 1977. Bibcode:1977Sci...197..566S. doi:10.1126/science.327549. PMID 327549.
Lee, SL.; Stenn, FF. (1978). „Characterization of mummy bone ochronotic pigment”. JAMA. 240 (2): 136–38. doi:10.1001/jama.1978.03290020058024. PMID 351220.

harvard.edu

adsabs.harvard.edu

„Biochemical identification of homogentisic acid pigment in an ochronotic egyptian mummy”. Science. 197 (4303): 566–68. 1977. Bibcode:1977Sci...197..566S. doi:10.1126/science.327549. PMID 327549.

nih.gov

ncbi.nlm.nih.gov

„Recent advances in management of alkaptonuria (invited review; best practice article)”. J. Clin. Pathol. 66 (5): 367–73. mai 2013. doi:10.1136/jclinpath-2012-200877. PMID 23486607.
„The biology of hyperpigmentation syndromes”. Pigment Cell Melanoma Res. 27 (4): 512–24. iulie 2014. doi:10.1111/pcmr.12235. PMID 24612852.
Lindner, Moritz; Bertelmann, Thomas (30 ianuarie 2014). „On the ocular findings in ochronosis: a systematic review of literature”. BMC Ophthalmology (în engleză). 14 (1): 12. doi:10.1186/1471-2415-14-12. ISSN 1471-2415. PMC 3915032 . PMID 24479547.
Zatkova A (decembrie 2011). „An update on molecular genetics of Alkaptonuria (AKU)”. J. Inherit. Metab. Dis. 34 (6): 1127–36. doi:10.1007/s10545-011-9363-z. PMID 21720873.
White, A.; c. Tchan, M. (2017). „Nitisinone-Induced Keratopathy in Alkaptonuria: A Challenging Diagnosis Despite Clinical Suspicion”. Jimd Reports. 40: 7–9. doi:10.1007/8904_2017_56. ISBN 978-3-662-57879-7. PMC 6122027 . PMID 28879639.
Stewart, R. M.; Briggs, M. C.; Jarvis, J. C.; Gallagher, J. A.; Ranganath, L. (2014). „Reversible Keratopathy Due to Hypertyrosinaemia Following Intermittent Low-Dose Nitisinone in Alkaptonuria: A Case Report”. Jimd Reports. 17: 1–6. doi:10.1007/8904_2014_307. ISBN 978-3-662-44577-8. PMC 4241204 . PMID 24997710.
Davison, A. S.; Strittmatter, N.; Sutherland, H.; Hughes, A. T.; Hughes, J.; Bou-Gharios, G.; Milan, A. M.; Goodwin, R. J.; Ranganath, L. R. (2019). „Assessing the effect of nitisinone induced hypertyrosinaemia on monoamine neurotransmitters in brain tissue from a murine model of alkaptonuria using mass spectrometry imaging”. Metabolomics. 15 (5): 68. doi:10.1007/s11306-019-1531-4. PMC 6488549 . PMID 31037385.
Norman, B. P.; Davison, A. S.; Hughes, J. H.; Sutherland, H.; Wilson, P. J.; Berry, N. G.; Hughes, A. T.; Milan, A. M.; Jarvis, J. C. (2021). „Metabolomic studies in the inborn error of metabolism alkaptonuria reveal new biotransformations in tyrosine metabolism”. Genes & Diseases. 9 (4): 1129–1142. doi:10.1016/j.gendis.2021.02.007. PMC 9170613 . PMID 35685462 Verificați valoarea |pmid= (ajutor).
Garrod AE (1902). „The incidence of alkaptonuria: a study in clinical individuality”. Lancet. 2 (4137): 1616–20. doi:10.1016/S0140-6736(01)41972-6. PMC 2230159 . PMID 8784780. Reproduced in Garrod AE (2002). „The incidence of alkaptonuria: a study in chemical individuality. 1902 classical article”. Yale Journal of Biology and Medicine. 75 (4): 221–31. PMC 2588790 . PMID 12784973.
„The nature of the defect in tyrosine metabolism in alcaptonuria”. Journal of Biological Chemistry. 230 (1): 251–60. 1 ianuarie 1958. doi:10.1016/S0021-9258(18)70560-7. PMID 13502394.
„The molecular basis of alkaptonuria”. Nature Genetics. 14 (1): 19–24. 1996. doi:10.1038/ng0996-19. PMID 8782815.
„Biochemical identification of homogentisic acid pigment in an ochronotic egyptian mummy”. Science. 197 (4303): 566–68. 1977. Bibcode:1977Sci...197..566S. doi:10.1126/science.327549. PMID 327549.
Lee, SL.; Stenn, FF. (1978). „Characterization of mummy bone ochronotic pigment”. JAMA. 240 (2): 136–38. doi:10.1001/jama.1978.03290020058024. PMID 351220.

rarediseases.info.nih.gov

Anonymous (18 martie 2016). „Alkaptonuria”. Accesat în 17 aprilie 2018.

pubmed.ncbi.nlm.nih.gov

Adnan, M.; Puranik, S. (2023). „Hypertyrosinemia”. StatPearls.

worldcat.org

Lindner, Moritz; Bertelmann, Thomas (30 ianuarie 2014). „On the ocular findings in ochronosis: a systematic review of literature”. BMC Ophthalmology (în engleză). 14 (1): 12. doi:10.1186/1471-2415-14-12. ISSN 1471-2415. PMC 3915032 . PMID 24479547.

zenodo.org

Garrod AE (1908). „The Croonian lectures on inborn errors of metabolism: lecture II: alkaptonuria”. Lancet. 2 (4428): 73–79. doi:10.1016/s0140-6736(01)78041-5.